ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ALLO is currently covered by 7 analysts with an average price target of $7.57. This is a potential upside of $6.94 (1101.59%) from yesterday's end of day stock price of $0.63.

Our record on ALLO covers 24 analysts since 2008; 7 cover it today. Of the 137 price targets those analysts set on ALLO, 31 were reached (23%). The highest performance score on ALLO belongs to Biren Amin of Piper Sandler: 11.06, with 2 of 10 targets met in 3 days on average. The latest calls: Reni Benjamin of JMP raised the target to $6 from $5 with a Buy rating on 17 Aug 2026; Roger Song of Jefferies kept the target at $10 with a Buy rating on 22 Apr 2026; Brian Cheng of JPMorgan updated the call with a Sell rating on 16 Apr 2026. Figures as of 18 Nov 2026.

Allogene Therapeutics's activity chart (see below) currently has 176 price targets and 164 ratings on display. The stock rating distribution of ALLO is 66.67% BUY, 22.22% HOLD and 11.11% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 25.48% of the time, taking 85.57 days on average.

Highest price target for ALLO is $11, Lowest price target is $3.85, average price target is $7.57.

Most recent stock forecast was given by RENI BENJAMIN from JMP on 17-Aug-2026. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 2 are a HOLD (22.22%), 6 are a BUY (66.67%), 1 are a SELL (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Aug-2026

$6

$4.96 (476.92%)

$5

3 months 4 days ago
(17-Aug-2026)

1/10 (10%)

$3.92 (188.46%)

148

Sell Since 16-Apr-2026

7 months 5 days ago
(16-Apr-2026)

0/3 (0%)

$2.86 (55.64%)

Buy Since 04-Apr-2023

$11

$9.96 (957.69%)

$12

7 months 5 days ago
(16-Apr-2026)

0/12 (0%)

$8.63 (364.14%)

Hold Since 21-Mar-2023

$3.85

$2.81 (270.19%)

$6

7 months 7 days ago
(14-Apr-2026)

1/2 (50%)

$1.57 (68.86%)

44

Buy Since 14-May-2025

$9

$7.96 (765.38%)

$9

7 months 7 days ago
(14-Apr-2026)

1/4 (25%)

$6.72 (294.74%)

19

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 86 days for the stock forecasts to be reached, with an average price target met ratio of 25.48%.

Which analyst most recently updated their price target on ALLO (Allogene Therapeutics)?

Reni Benjamin

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Reni Benjamin has 8 price targets and 6 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Salveen Richter with the highest potential upside of $29.96

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Asthika Goonewardene with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?